Comparative Study of Propranolol hydrochloride Release from Matrix Tablets with Kollidon®SR or Hydroxy Propyl Methyl Cellulose

Abstract

The release of propranolol hydrochloride from matrix tablets with hydroxy propyl methyl cellulose (HPMC K15M) or KollidonSR at different concentrations was investigated with a view to developing twice daily sustained release dosage form. A hydrophilic matrix-based tablet using different concentrations of HPMC K15M or KollidonSR was developed using direct compression technique to contain 80 mg of propranolol hydrochloride. The resulting matrix tablets prepared with HPMC K15M or KollidonSR fulfilled all the official requirements of tablet dosage forms. Formulations were evaluated for the release of propranolol hydrochloride over a period of 12 h in pH 6.8 phosphate buffer using USP type II dissolution apparatus. Propranolol hydrochloride and pure KollidonSR or HPMC K15M compatibility interactions was investigated by using Fourier-transform infrared (FTIR) spectroscopy and differential scanning calorimetry (DSC). FTIR spectroscopic and DSC studies revealed that there was no well defined chemical interaction between propranolol hydrochloride with KollidonSR or HPMC K15M. Tablets were exposed to 40 degrees C/75% of RH in open disc for stability. The in vitro drug release study revealed that HPMC K15 at a concentration of 40% of the dosage form weight was able to control the release of propranolol hydrochloride for 12 h, exhibit non-Fickian diffusion with first-order release kinetics where as at 40% KollidonSR same dosage forms show zero-order release kinetics. In conclusion, the in vitro release profile and the mathematical models indicate that release of propranolol hydrochloride can be effectively controlled from a single tablet using HPMC K15M or KollidonSR matrix system.

Starch-free grewia gum matrices: Compaction, swelling, erosion and drug release behaviour

“…The different viscosity grades available afford the choice of material forming more or less viscous gels. Furthermore, the non-ionic nature of the material enables pH -independent release of drug from tablet matrices (Merchant et al, 2006;Sahoo et al, 2008;Mughal et al, 2011).…”

Use of hydrophilic and hydrophobic polymers for the development of controlled release tizanidine matrix tablets

“…Jan et al (2011) successfully developed sustained release Ketoprofen tablets with different grades of Ethocel FP and found release kinetics nearly zeroorder. Sahoo et al (2008) prepared controlled release propranalol hydrochloride tablet by direct compression with 40% Kollidon SR that showed a zero-order release kinetics.…”

Development of Modified-Release Tablets of Zolpidem Tartrate by Biphasic Quick/Slow Delivery System

“…It has been used widely for the development of sustained-release dosage forms such as matrix tablets of high water-soluble drugs (7). A comparative study of propranolol hydrochloride release from matrix tablets with Kollidon® sustained release (SR) or hydroxypropyl methyl cellulose has been reported (8). The possible mechanisms of drug dispersion using different grades of HPMC have been discussed for directly compressed indomethacin tablets (9).…”